ArticleDiscover oncology2025
Identification of 5mC regulatory factors mediating methylation patterns and prognosis models in head and neck squamous cell carcinoma.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study explores the role of 5mC regulatory genes in head and neck squamous cell carcinoma (HNSCC), focusing on their association with tumor progression, metastasis, and prognosis. A prognostic model was also developed to predict patient survival. MATERIALS AND
methodsUsing expression profile data from the GEO and TCGA databases, the study analyzed the differential expression of 5mC-related genes, their connection with somatic mutations, and their impact on the immune microenvironment. A prognostic risk model based on these genes was constructed through the differential expression of 5mC-related genes.
results(1) Several 5mC regulatory factors were found to be abnormally expressed in HNSCC, with a significant association with somatic mutations. (2) Different 5mC methylation regulation patterns showed variations in immune infiltration, immune checkpoint expression, tumor mutation burden, and cancer stem cell gene set expression, potentially influencing immunotherapy effectiveness and prognosis. (3) Prognosis-related risk genes, such as DNMT1 and TET2, were identified as predictors of survival outcomes in HNSCC patients.
conclusionsThe methylation patterns of 5mC regulatory factors are critical in HNSCC progression and are closely linked to tumor microenvironment infiltration. These findings offer new perspectives for treatment strategies and prognosis prediction in HNSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.